Cognitive remission: a novel objective for the treatment of major depression?

BMC Medicine
Beatrice BortolatoAndré F Carvalho

Abstract

Cognitive dysfunction in major depressive disorder (MDD) encompasses several domains, including but not limited to executive function, verbal memory, and attention. Furthermore, cognitive dysfunction is a frequent residual manifestation in depression and may persist during the remitted phase. Cognitive deficits may also impede functional recovery, including workforce performance, in patients with MDD. The overarching aims of this opinion article are to critically evaluate the effects of available antidepressants as well as novel therapeutic targets on neurocognitive dysfunction in MDD. Conventional antidepressant drugs mitigate cognitive dysfunction in some people with MDD. However, a significant proportion of MDD patients continue to experience significant cognitive impairment. Two multicenter randomized controlled trials (RCTs) reported that vortioxetine, a multimodal antidepressant, has significant precognitive effects in MDD unrelated to mood improvement. Lisdexamfetamine dimesylate was shown to alleviate executive dysfunction in an RCT of adults after full or partial remission of MDD. Preliminary evidence also indicates that erythropoietin may alleviate cognitive dysfunction in MDD. Several other novel agents may be repurp...Continue Reading

References

Apr 1, 1979·The British Journal of Psychiatry : the Journal of Mental Science·S A Montgomery, M Asberg
Jan 1, 1990·Psychopharmacology·C Mondadori, P Etienne
Dec 1, 1967·The British Journal of Social and Clinical Psychology·M Hamilton
Mar 11, 2000·Archives of General Psychiatry·G S AlexopoulosJ Hull
Aug 15, 2000·Journal of Affective Disorders·J J DunkinS Rosenberg-Thompson
Oct 6, 2000·Acta Psychiatrica Scandinavica. Supplementum·S PerettiI Hindmarch
Nov 25, 2000·Medical Hypotheses·M R Salazar
Mar 7, 2001·The British Journal of Psychiatry : the Journal of Mental Science·M P AustinG M Goodwin
Jan 8, 2004·Journal of Clinical Psychopharmacology·Charles DeBattistaJennifer Poirier
Jan 20, 2004·The Journal of Clinical Psychiatry·Paul E GreenbergPatricia K Corey-Lisle
Feb 26, 2004·Lancet Neurology·Suzanne Craft, G Stennis Watson
Mar 19, 2004·Journal of the American College of Cardiology·Barbara WirleitnerDietmar Fuchs
Jun 17, 2004·Journal of Basic and Clinical Physiology and Pharmacology·Jan J BraszkoPaul R Gard
Jul 3, 2004·Biological Psychiatry·Meena VythilingamJ Douglas Bremner
Sep 2, 2004·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Guy G PotterK Ranga Rama Krishnan
Oct 7, 2004·The American Journal of Psychiatry·Philip S WangRonald C Kessler
Oct 19, 2004·Journal of Affective Disorders·Petra Weiland-FiedlerAlexander Neumeister
Mar 29, 2005·European Archives of Psychiatry and Clinical Neuroscience·Eva BiringerAnders Lund
Jan 5, 2006·The American Journal of Psychiatry·Bonnie P TaylorFrederic M Quitkin
Jul 21, 2006·Journal of Clinical Psychopharmacology·Tonita E WroolieNatalie L Rasgon
Sep 2, 2006·The American Journal of Psychiatry·David A AdlerDebra Lerner
Oct 4, 2006·Archives of General Psychiatry·Maura L Furey, Wayne C Drevets
Oct 19, 2006·Psychiatry Research·Judith JaegerSara Davis-Conway
Jan 2, 2007·The Journal of Clinical Psychiatry·Maurizio FavaGeorge I Papakostas
Jul 28, 2007·Journal of Affective Disorders·Michael BerkMauricio Tohen
Aug 10, 2007·Expert Opinion on Pharmacotherapy·Roger S McIntyreSidney H Kennedy
Sep 19, 2007·Journal of Clinical Pharmacy and Therapeutics·A F CarvalhoM C O Lima
Nov 6, 2007·Frontiers in Bioscience : a Journal and Virtual Library·Ramya KapadiaRaghu Vemuganti
Dec 7, 2007·International Journal of Geriatric Psychiatry·Paul E HoltzheimerWilliam M McDonald
May 16, 2008·Journal of Clinical Psychopharmacology·Safa Elgamal, Glenda MacQueen
May 22, 2008·Expert Opinion on Investigational Drugs·Joanna K SoczynskaRoger S McIntyre
Jul 17, 2008·Journal of Neural Transmission·Marianne GorlynJ John Mann
Aug 14, 2008·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·Tyler J StoryDavid C Steffens
Oct 16, 2008·Acta Psychiatrica Scandinavica·M A Buist-BouwmanUNKNOWN ESEMeD/MHEDEA 2000 investigators
Nov 11, 2008·Neuroscience and Biobehavioral Reviews·J McAfoose, B T Baune

❮ Previous
Next ❯

Citations

Jun 29, 2016·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Caroline Vintergaard OttKamilla W Miskowiak
Sep 7, 2016·Drug Development Research·Nataša Karas Kuželički
Sep 7, 2016·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Kamilla W MiskowiakLars V Kessing
Oct 18, 2016·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·K W MiskowiakL V Kessing
Mar 10, 2017·Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology·Hamidreza JamilianZatollah Asemi
Jul 30, 2017·The Australian and New Zealand Journal of Psychiatry·Daniel J BrownsteinBrisa S Fernandes
Nov 22, 2017·Applied Neuropsychology. Adult·Peter NeuPeter Schlattmann
Jul 25, 2018·Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·A E BobrovE M Mutnykh
Apr 26, 2019·Expert Review of Neurotherapeutics·Matthew J KnightBernhard T Baune
Aug 2, 2017·Metabolic Brain Disease·Anzelle DelportJacobus P Petzer
Jan 3, 2020·Journal of Psychosocial Nursing and Mental Health Services·Barbara J Limandri
Jun 25, 2020·Social Cognitive and Affective Neuroscience·Luis C FarhatAndre R Brunoni
Mar 20, 2020·Current Pharmaceutical Design·Vicent Balanzá-MartínezPilar López-García
Apr 4, 2017·European Psychiatry : the Journal of the Association of European Psychiatrists·E SalagreB S Fernandes
Dec 11, 2019·International Journal of Environmental Research and Public Health·Jae Han KimEun-Cheol Park
Mar 11, 2017·European Journal of Clinical Pharmacology·Nathalie Pruckner, Vjera Holthoff-Detto
May 13, 2017·Pharmacological Reports : PR·Magdalena Sowa-KućmaMagdalena Koperny
Jun 24, 2020·European Psychiatry : the Journal of the Association of European Psychiatrists·Clara López-SolàNarcís Cardoner
Dec 17, 2020·The Australian and New Zealand Journal of Psychiatry·Wenjian TanJie Yang
Jan 1, 2019·Journal of Affective Disorders·Christine Mohn, Bjørn Rishovd Rund
Nov 24, 2020·Journal of the American Medical Directors Association·André HajekHans-Helmut König
Sep 12, 2019·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Gerwyn MorrisMichael Berk

❮ Previous
Next ❯

Clinical Trials Mentioned

NCT01148979
NCT00570050

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

CNS & Neurological Disorders Drug Targets
André F CarvalhoRoger S McIntyre
Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakológiai Egyesület lapja = official journal of the Hungarian Association of Psychopharmacology
Anikó EgerháziRoland Berecz
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
Brisa SoléEduard Vieta
© 2022 Meta ULC. All rights reserved